Atrial Natriuretic Peptide and Type 2 Diabetes Development – Biomarker and Genotype Association Study

We have recently shown that low plasma levels of mid-regional atrial natriuretic peptide (MR-ANP) predict development of diabetes and glucose progression over time, independently of known risk factors for diabetes development. However, since MR-ANP levels might be influenced by unknown factors causi...

Full description

Saved in:
Bibliographic Details
Published inPloS one Vol. 9; no. 2; p. e89201
Main Authors Jujić, Amra, Nilsson, Peter M., Engström, Gunnar, Hedblad, Bo, Melander, Olle, Magnusson, Martin
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 19.02.2014
Public Library of Science (PLoS)
Subjects
Online AccessGet full text

Cover

Loading…
Abstract We have recently shown that low plasma levels of mid-regional atrial natriuretic peptide (MR-ANP) predict development of diabetes and glucose progression over time, independently of known risk factors for diabetes development. However, since MR-ANP levels might be influenced by unknown factors causing diabetes, we cannot rule out that such relationship might be confounded. Previous studies have shown an association of a single nucleotide polymorphism rs5068 on the natriuretic peptide precursor A (NPPA) locus gene with higher levels of circulating ANP. Since gene variants are inherited randomly and not subject to confounding, we aimed to investigate whether the variant rs5068 within the NPPA locus is associated with incident type 2 diabetes. We genotyped the variant rs5068 within the NPPA locus in 27,307 individuals without known diabetes from the Malmö Diet Cancer Study. Incident diabetes was retrieved through national and regional registers (median follow-up time of 14 years, 2,823 incident diabetes cases). In Cox regression analysis adjusted for age, sex and BMI, we found that the carriers of at least one copy of the G allele of rs5068 had lower likelihood of incident diabetes within 14 years (HR = 0.88, 95% CI 0.78-0.99, p = 0.037). Our results indicate a role of the ANP system in the etiology of type 2 diabetes and might help provide insight in the metabolic actions of natriuretic peptides and the pathophysiology of type 2 diabetes.
AbstractList Background We have recently shown that low plasma levels of mid-regional atrial natriuretic peptide (MR-ANP) predict development of diabetes and glucose progression over time, independently of known risk factors for diabetes development. However, since MR-ANP levels might be influenced by unknown factors causing diabetes, we cannot rule out that such relationship might be confounded. Previous studies have shown an association of a single nucleotide polymorphism rs5068 on the natriuretic peptide precursor A (NPPA) locus gene with higher levels of circulating ANP. Since gene variants are inherited randomly and not subject to confounding, we aimed to investigate whether the variant rs5068 within the NPPA locus is associated with incident type 2 diabetes. Methods We genotyped the variant rs5068 within the NPPA locus in 27,307 individuals without known diabetes from the Malmö Diet Cancer Study. Incident diabetes was retrieved through national and regional registers (median follow-up time of 14 years, 2,823 incident diabetes cases). Results In Cox regression analysis adjusted for age, sex and BMI, we found that the carriers of at least one copy of the G allele of rs5068 had lower likelihood of incident diabetes within 14 years (HR = 0.88, 95% CI 0.78–0.99, p = 0.037). Conclusion Our results indicate a role of the ANP system in the etiology of type 2 diabetes and might help provide insight in the metabolic actions of natriuretic peptides and the pathophysiology of type 2 diabetes.
We have recently shown that low plasma levels of mid-regional atrial natriuretic peptide (MR-ANP) predict development of diabetes and glucose progression over time, independently of known risk factors for diabetes development. However, since MR-ANP levels might be influenced by unknown factors causing diabetes, we cannot rule out that such relationship might be confounded. Previous studies have shown an association of a single nucleotide polymorphism rs5068 on the natriuretic peptide precursor A (NPPA) locus gene with higher levels of circulating ANP. Since gene variants are inherited randomly and not subject to confounding, we aimed to investigate whether the variant rs5068 within the NPPA locus is associated with incident type 2 diabetes. We genotyped the variant rs5068 within the NPPA locus in 27,307 individuals without known diabetes from the Malmö Diet Cancer Study. Incident diabetes was retrieved through national and regional registers (median follow-up time of 14 years, 2,823 incident diabetes cases). In Cox regression analysis adjusted for age, sex and BMI, we found that the carriers of at least one copy of the G allele of rs5068 had lower likelihood of incident diabetes within 14 years (HR = 0.88, 95% CI 0.78-0.99, p = 0.037). Our results indicate a role of the ANP system in the etiology of type 2 diabetes and might help provide insight in the metabolic actions of natriuretic peptides and the pathophysiology of type 2 diabetes.
BackgroundWe have recently shown that low plasma levels of mid-regional atrial natriuretic peptide (MR-ANP) predict development of diabetes and glucose progression over time, independently of known risk factors for diabetes development. However, since MR-ANP levels might be influenced by unknown factors causing diabetes, we cannot rule out that such relationship might be confounded. Previous studies have shown an association of a single nucleotide polymorphism rs5068 on the natriuretic peptide precursor A (NPPA) locus gene with higher levels of circulating ANP. Since gene variants are inherited randomly and not subject to confounding, we aimed to investigate whether the variant rs5068 within the NPPA locus is associated with incident type 2 diabetes.MethodsWe genotyped the variant rs5068 within the NPPA locus in 27,307 individuals without known diabetes from the Malmö Diet Cancer Study. Incident diabetes was retrieved through national and regional registers (median follow-up time of 14 years, 2,823 incident diabetes cases).ResultsIn Cox regression analysis adjusted for age, sex and BMI, we found that the carriers of at least one copy of the G allele of rs5068 had lower likelihood of incident diabetes within 14 years (HR = 0.88, 95% CI 0.78-0.99, p = 0.037).ConclusionOur results indicate a role of the ANP system in the etiology of type 2 diabetes and might help provide insight in the metabolic actions of natriuretic peptides and the pathophysiology of type 2 diabetes.
We have recently shown that low plasma levels of mid-regional atrial natriuretic peptide (MR-ANP) predict development of diabetes and glucose progression over time, independently of known risk factors for diabetes development. However, since MR-ANP levels might be influenced by unknown factors causing diabetes, we cannot rule out that such relationship might be confounded. Previous studies have shown an association of a single nucleotide polymorphism rs5068 on the natriuretic peptide precursor A (NPPA) locus gene with higher levels of circulating ANP. Since gene variants are inherited randomly and not subject to confounding, we aimed to investigate whether the variant rs5068 within the NPPA locus is associated with incident type 2 diabetes.
We have recently shown that low plasma levels of mid-regional atrial natriuretic peptide (MR-ANP) predict development of diabetes and glucose progression over time, independently of known risk factors for diabetes development. However, since MR-ANP levels might be influenced by unknown factors causing diabetes, we cannot rule out that such relationship might be confounded. Previous studies have shown an association of a single nucleotide polymorphism rs5068 on the natriuretic peptide precursor A (NPPA) locus gene with higher levels of circulating ANP. Since gene variants are inherited randomly and not subject to confounding, we aimed to investigate whether the variant rs5068 within the NPPA locus is associated with incident type 2 diabetes.BACKGROUNDWe have recently shown that low plasma levels of mid-regional atrial natriuretic peptide (MR-ANP) predict development of diabetes and glucose progression over time, independently of known risk factors for diabetes development. However, since MR-ANP levels might be influenced by unknown factors causing diabetes, we cannot rule out that such relationship might be confounded. Previous studies have shown an association of a single nucleotide polymorphism rs5068 on the natriuretic peptide precursor A (NPPA) locus gene with higher levels of circulating ANP. Since gene variants are inherited randomly and not subject to confounding, we aimed to investigate whether the variant rs5068 within the NPPA locus is associated with incident type 2 diabetes.We genotyped the variant rs5068 within the NPPA locus in 27,307 individuals without known diabetes from the Malmö Diet Cancer Study. Incident diabetes was retrieved through national and regional registers (median follow-up time of 14 years, 2,823 incident diabetes cases).METHODSWe genotyped the variant rs5068 within the NPPA locus in 27,307 individuals without known diabetes from the Malmö Diet Cancer Study. Incident diabetes was retrieved through national and regional registers (median follow-up time of 14 years, 2,823 incident diabetes cases).In Cox regression analysis adjusted for age, sex and BMI, we found that the carriers of at least one copy of the G allele of rs5068 had lower likelihood of incident diabetes within 14 years (HR = 0.88, 95% CI 0.78-0.99, p = 0.037).RESULTSIn Cox regression analysis adjusted for age, sex and BMI, we found that the carriers of at least one copy of the G allele of rs5068 had lower likelihood of incident diabetes within 14 years (HR = 0.88, 95% CI 0.78-0.99, p = 0.037).Our results indicate a role of the ANP system in the etiology of type 2 diabetes and might help provide insight in the metabolic actions of natriuretic peptides and the pathophysiology of type 2 diabetes.CONCLUSIONOur results indicate a role of the ANP system in the etiology of type 2 diabetes and might help provide insight in the metabolic actions of natriuretic peptides and the pathophysiology of type 2 diabetes.
We have recently shown that low plasma levels of mid-regional atrial natriuretic peptide (MR-ANP) predict development of diabetes and glucose progression over time, independently of known risk factors for diabetes development. However, since MR-ANP levels might be influenced by unknown factors causing diabetes, we cannot rule out that such relationship might be confounded. Previous studies have shown an association of a single nucleotide polymorphism rs5068 on the natriuretic peptide precursor A (NPPA) locus gene with higher levels of circulating ANP. Since gene variants are inherited randomly and not subject to confounding, we aimed to investigate whether the variant rs5068 within the NPPA locus is associated with incident type 2 diabetes. We genotyped the variant rs5068 within the NPPA locus in 27,307 individuals without known diabetes from the Malmö Diet Cancer Study. Incident diabetes was retrieved through national and regional registers (median follow-up time of 14 years, 2,823 incident diabetes cases). In Cox regression analysis adjusted for age, sex and BMI, we found that the carriers of at least one copy of the G allele of rs5068 had lower likelihood of incident diabetes within 14 years (HR = 0.88, 95% CI 0.78-0.99, p = 0.037). Our results indicate a role of the ANP system in the etiology of type 2 diabetes and might help provide insight in the metabolic actions of natriuretic peptides and the pathophysiology of type 2 diabetes.
Background We have recently shown that low plasma levels of mid-regional atrial natriuretic peptide (MR-ANP) predict development of diabetes and glucose progression over time, independently of known risk factors for diabetes development. However, since MR-ANP levels might be influenced by unknown factors causing diabetes, we cannot rule out that such relationship might be confounded. Previous studies have shown an association of a single nucleotide polymorphism rs5068 on the natriuretic peptide precursor A (NPPA) locus gene with higher levels of circulating ANP. Since gene variants are inherited randomly and not subject to confounding, we aimed to investigate whether the variant rs5068 within the NPPA locus is associated with incident type 2 diabetes. Methods We genotyped the variant rs5068 within the NPPA locus in 27,307 individuals without known diabetes from the Malmö Diet Cancer Study. Incident diabetes was retrieved through national and regional registers (median follow-up time of 14 years, 2,823 incident diabetes cases). Results In Cox regression analysis adjusted for age, sex and BMI, we found that the carriers of at least one copy of the G allele of rs5068 had lower likelihood of incident diabetes within 14 years (HR = 0.88, 95% CI 0.78–0.99, p = 0.037). Conclusion Our results indicate a role of the ANP system in the etiology of type 2 diabetes and might help provide insight in the metabolic actions of natriuretic peptides and the pathophysiology of type 2 diabetes.
Audience Academic
Author Magnusson, Martin
Engström, Gunnar
Hedblad, Bo
Nilsson, Peter M.
Jujić, Amra
Melander, Olle
AuthorAffiliation 3 Center of Emergency Medicine, Skåne University Hospital, Malmö, Sweden
University of Lille Nord de France, France
1 Department of Heart Failure and Valvular Disease, Skåne University Hospital, Malmö, Sweden
2 Department of Clinical Sciences, Lund University, Malmö, Sweden
AuthorAffiliation_xml – name: 1 Department of Heart Failure and Valvular Disease, Skåne University Hospital, Malmö, Sweden
– name: 2 Department of Clinical Sciences, Lund University, Malmö, Sweden
– name: 3 Center of Emergency Medicine, Skåne University Hospital, Malmö, Sweden
– name: University of Lille Nord de France, France
Author_xml – sequence: 1
  givenname: Amra
  surname: Jujić
  fullname: Jujić, Amra
– sequence: 2
  givenname: Peter M.
  surname: Nilsson
  fullname: Nilsson, Peter M.
– sequence: 3
  givenname: Gunnar
  surname: Engström
  fullname: Engström, Gunnar
– sequence: 4
  givenname: Bo
  surname: Hedblad
  fullname: Hedblad, Bo
– sequence: 5
  givenname: Olle
  surname: Melander
  fullname: Melander, Olle
– sequence: 6
  givenname: Martin
  surname: Magnusson
  fullname: Magnusson, Martin
BackLink https://www.ncbi.nlm.nih.gov/pubmed/24586593$$D View this record in MEDLINE/PubMed
https://lup.lub.lu.se/record/4384156$$DView record from Swedish Publication Index
oai:portal.research.lu.se:publications/f85f6525-b864-48e1-acc2-d13083e4cebc$$DView record from Swedish Publication Index
BookMark eNqNk9tu1DAQhiMEogd4AwSRkBBc7OJD7NhcIC0tlEoVRbRwa9nOZNfFG4c4KfSOd-ANeRK8h6JuVVAVRY4m3_wz-Sezk91tQgNZ9gijMaYlfnkWhq7Rftym8BghIQnCd7JtLCkZcYLo3SvPW9lOjGcIMSo4v59tkYIJziTdzqaTvnPa5x90OocOemfzj9D2roJcN1V-etFCTvJ9pw30EPN9OAcf2jk0ff7756_8jQtz3X2FbkkfQBP6RcYkxmCd7l1o8pN-qC4eZPdq7SM8XJ-72ed3b0_33o-Ojg8O9yZHIytx2Y9qzLQohRFW1MYSbTDwsqIIS0IsY8aUrMaYag6CsspIYYkssSgkaMQJY3Q3e7LSbX2Iau1RVJghVGAkZZmIwxVRBX2m2s6l_i9U0E4tA6GbKt0lGzwobjAFiQzhTBcWVRpVUnLNDKeaMrzQ0iut-B3awWyotaHrtVcdRNCdnSk_qAgqUd7ZpTFR1YLVnBGmjOCFKgRgpa0lqsIUCQqFBWNTjaN_1vBDm26z1r6l3Ou1QYOZQ2XTILvU5kbnG28aN1PTcK6oJJJTlASerwW68G2A2Ku5ixa81w2EYWl1gVlB-MKep9fQmweypqY6ee6aOqS6diGqJkUpSilRUSRqfAOVrgrmzqYdqF2KbyS82EhITA8_-qkeYlSHJ59uzx5_2WSfXWFnoH0_i8EPq5FugI-vOv3X4svlS8CrFWC7EGMHtbKuX_4a6dOcVxipxaZfmqYWm67Wm56Si2vJl_r_TfsDUjJY2w
CitedBy_id crossref_primary_10_4103_bbrj_bbrj_90_22
crossref_primary_10_2337_dc21_0811
crossref_primary_10_1080_14728222_2016_1254198
crossref_primary_10_1016_j_jss_2015_10_045
crossref_primary_10_1007_s00109_017_1582_9
crossref_primary_10_1007_s42000_020_00222_w
crossref_primary_10_36660_abc_20200735
crossref_primary_10_3390_ijms232214415
crossref_primary_10_1097_HCO_0000000000000630
crossref_primary_10_1186_s12933_018_0747_3
crossref_primary_10_1111_obr_12598
crossref_primary_10_1186_s12933_024_02475_w
crossref_primary_10_3390_ijms20133265
crossref_primary_10_1007_s11892_018_1009_1
crossref_primary_10_1016_j_biochi_2015_05_017
crossref_primary_10_1152_ajprenal_00614_2020
crossref_primary_10_1186_s12916_022_02682_w
crossref_primary_10_1126_sciadv_adl4374
crossref_primary_10_1253_circj_CJ_17_0499
crossref_primary_10_1210_endrev_bnac029
crossref_primary_10_1371_journal_pone_0189858
crossref_primary_10_1016_j_foodres_2015_06_032
crossref_primary_10_1177_0300060518786907
crossref_primary_10_1016_j_peptides_2020_170352
crossref_primary_10_1093_gerona_glz286
crossref_primary_10_1016_S2213_8587_19_30119_6
crossref_primary_10_1016_j_ejphar_2024_177053
crossref_primary_10_1039_C6SC05044A
crossref_primary_10_1177_2042018820970444
crossref_primary_10_1002_cpt_455
crossref_primary_10_1016_S1957_2557_19_30091_4
crossref_primary_10_1515_jbcpp_2017_0146
crossref_primary_10_1016_j_pharmthera_2018_08_015
crossref_primary_10_1007_s11154_016_9348_1
crossref_primary_10_1007_s00018_020_03573_0
crossref_primary_10_1016_j_biopha_2017_05_136
crossref_primary_10_1210_jendso_bvaa052
crossref_primary_10_1161_HYPERTENSIONAHA_118_11081
crossref_primary_10_1159_000521295
crossref_primary_10_2337_dc14_0669
Cites_doi 10.1371/journal.pmed.1001112
10.1023/A:1020036805655
10.1016/j.jacc.2011.05.011
10.1002/dmrr.611
10.1016/j.yjmcc.2011.01.010
10.1038/ng.328
10.1038/ng.361
10.2337/diabetes.54.4.991
10.1038/ijo.2012.88
10.1007/s001250050880
10.1172/JCI67383
10.1046/j.1463-1326.2003.00265.x
10.1002/pds.1294
10.1126/science.7839143
10.1111/j.1365-2796.1993.tb00645.x
10.2337/dc08-0662
10.1007/s001250051573
10.1161/01.HYP.0000179575.13739.72
10.1161/CIRCULATIONAHA.106.655142
10.1038/378065a0
10.1161/01.CIR.0000141736.76561.78
10.1186/1471-2458-11-450
10.1161/01.STR.0000158925.12740.87
10.2337/dc12-2337
10.1172/JCI118623
10.1097/00005344-198611000-00005
10.1016/0196-9781(96)00152-0
10.2337/diacare.27.8.1929
10.1373/clinchem.2003.028316
10.2337/diabetes.51.6.1699
10.1111/j.1365-2796.1994.tb01263.x
10.1056/NEJM199807303390507
10.1097/00008469-200112000-00003
10.1186/1471-2350-14-64
10.1056/NEJMoa0801869
10.1161/ATVBAHA.107.142679
10.1161/01.CIR.0000140265.21608.8E
10.1371/journal.pone.0010100
10.1097/HJH.0b013e32803cae3c
10.1210/jc.2011-2425
ContentType Journal Article
Copyright COPYRIGHT 2014 Public Library of Science
2014 Jujić et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2014 Jujić et al 2014 Jujić et al
Copyright_xml – notice: COPYRIGHT 2014 Public Library of Science
– notice: 2014 Jujić et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2014 Jujić et al 2014 Jujić et al
CorporateAuthor Kardiovaskulär forskning - epidemiologi
Lunds universitet
Profile areas and other strong research environments
Department of Clinical Sciences, Malmö
Lund University
Kardiovaskulär forskning - hypertoni
Strategiska forskningsområden (SFO)
EpiHealth: Epidemiology for Health
EXODIAB: Excellence of Diabetes Research in Sweden
Faculty of Medicine
Internmedicin - epidemiologi
Strategic research areas (SRA)
Medicinska fakulteten
Cardiovascular Research - Epidemiology
Profilområden och andra starka forskningsmiljöer
Cardiovascular Research - Hypertension
Institutionen för kliniska vetenskaper, Malmö
Internal Medicine - Epidemiology
CorporateAuthor_xml – name: Faculty of Medicine
– name: Medicinska fakulteten
– name: Cardiovascular Research - Hypertension
– name: Kardiovaskulär forskning - hypertoni
– name: Kardiovaskulär forskning - epidemiologi
– name: Strategiska forskningsområden (SFO)
– name: EpiHealth: Epidemiology for Health
– name: Institutionen för kliniska vetenskaper, Malmö
– name: Internal Medicine - Epidemiology
– name: Strategic research areas (SRA)
– name: Lunds universitet
– name: Profilområden och andra starka forskningsmiljöer
– name: Lund University
– name: EXODIAB: Excellence of Diabetes Research in Sweden
– name: Profile areas and other strong research environments
– name: Internmedicin - epidemiologi
– name: Cardiovascular Research - Epidemiology
– name: Department of Clinical Sciences, Malmö
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
IOV
ISR
3V.
7QG
7QL
7QO
7RV
7SN
7SS
7T5
7TG
7TM
7U9
7X2
7X7
7XB
88E
8AO
8C1
8FD
8FE
8FG
8FH
8FI
8FJ
8FK
ABJCF
ABUWG
AEUYN
AFKRA
ARAPS
ATCPS
AZQEC
BBNVY
BENPR
BGLVJ
BHPHI
C1K
CCPQU
D1I
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
KB.
KB0
KL.
L6V
LK8
M0K
M0S
M1P
M7N
M7P
M7S
NAPCQ
P5Z
P62
P64
PATMY
PDBOC
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
PTHSS
PYCSY
RC3
7X8
5PM
ADTPV
AGCHP
AOWAS
D8T
D95
ZZAVC
DOA
DOI 10.1371/journal.pone.0089201
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Gale In Context: Opposing Viewpoints
Gale In Context: Science
ProQuest Central (Corporate)
Animal Behavior Abstracts
Bacteriology Abstracts (Microbiology B)
Biotechnology Research Abstracts
Nursing & Allied Health Database
Ecology Abstracts
Entomology Abstracts (Full archive)
Immunology Abstracts
Meteorological & Geoastrophysical Abstracts
Nucleic Acids Abstracts
Virology and AIDS Abstracts
Agricultural Science Collection
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Public Health Database
Technology Research Database
ProQuest SciTech Collection
ProQuest Technology Collection
ProQuest Natural Science Journals
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Materials Science & Engineering Collection
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
Advanced Technologies & Aerospace Collection
Agricultural & Environmental Science Collection
ProQuest Central Essentials - QC
Biological Science Collection
ProQuest Central
Technology Collection
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One
ProQuest Materials Science Collection
ProQuest Central
Engineering Research Database
Proquest Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
ProQuest SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Materials Science Database
Nursing & Allied Health Database (Alumni Edition)
Meteorological & Geoastrophysical Abstracts - Academic
ProQuest Engineering Collection
Biological Sciences
Agricultural Science Database
ProQuest Health & Medical Collection
Medical Database
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biological Science Database
Engineering Database
Nursing & Allied Health Premium
Advanced Technologies & Aerospace Collection
ProQuest Advanced Technologies & Aerospace Collection
Biotechnology and BioEngineering Abstracts
Environmental Science Database
Materials Science Collection
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
Engineering Collection
Environmental Science Collection
Genetics Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
SwePub
SWEPUB Lunds universitet full text
SwePub Articles
SWEPUB Freely available online
SWEPUB Lunds universitet
SwePub Articles full text
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Agricultural Science Database
Publicly Available Content Database
ProQuest Central Student
ProQuest Advanced Technologies & Aerospace Collection
ProQuest Central Essentials
Nucleic Acids Abstracts
SciTech Premium Collection
ProQuest Central China
Environmental Sciences and Pollution Management
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
Health Research Premium Collection
Meteorological & Geoastrophysical Abstracts
Natural Science Collection
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Engineering Collection
Advanced Technologies & Aerospace Collection
Engineering Database
Virology and AIDS Abstracts
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
Agricultural Science Collection
ProQuest Hospital Collection
ProQuest Technology Collection
Health Research Premium Collection (Alumni)
Biological Science Database
Ecology Abstracts
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
Environmental Science Collection
Entomology Abstracts
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
Environmental Science Database
ProQuest Nursing & Allied Health Source (Alumni)
Engineering Research Database
ProQuest One Academic
Meteorological & Geoastrophysical Abstracts - Academic
ProQuest One Academic (New)
Technology Collection
Technology Research Database
ProQuest One Academic Middle East (New)
Materials Science Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central
ProQuest Health & Medical Research Collection
Genetics Abstracts
ProQuest Engineering Collection
Biotechnology Research Abstracts
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Agricultural & Environmental Science Collection
AIDS and Cancer Research Abstracts
Materials Science Database
ProQuest Materials Science Collection
ProQuest Public Health
ProQuest Nursing & Allied Health Source
ProQuest SciTech Collection
Advanced Technologies & Aerospace Database
ProQuest Medical Library
Animal Behavior Abstracts
Materials Science & Engineering Collection
Immunology Abstracts
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList Agricultural Science Database






MEDLINE - Academic
MEDLINE



Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: 8FG
  name: ProQuest Technology Collection
  url: https://search.proquest.com/technologycollection1
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Sciences (General)
Public Health
Medicine
Biology
DocumentTitleAlternate Natriuretic Peptides and Diabetes Development
EISSN 1932-6203
ExternalDocumentID 1500410997
oai_doaj_org_article_6b13e90b265a4c0da0d996a5b63a3517
oai_portal_research_lu_se_publications_f85f6525_b864_48e1_acc2_d13083e4cebc
oai_lup_lub_lu_se_f85f6525_b864_48e1_acc2_d13083e4cebc
PMC3929630
3223821451
A478799044
24586593
10_1371_journal_pone_0089201
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations Sweden
GeographicLocations_xml – name: Sweden
GroupedDBID ---
123
29O
2WC
53G
5VS
7RV
7X2
7X7
7XC
88E
8AO
8C1
8CJ
8FE
8FG
8FH
8FI
8FJ
A8Z
AAFWJ
AAUCC
AAWOE
AAYXX
ABDBF
ABIVO
ABJCF
ABUWG
ACGFO
ACIHN
ACIWK
ACPRK
ACUHS
ADBBV
ADRAZ
AEAQA
AENEX
AEUYN
AFKRA
AFPKN
AFRAH
AHMBA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
APEBS
ARAPS
ATCPS
BAWUL
BBNVY
BCNDV
BENPR
BGLVJ
BHPHI
BKEYQ
BPHCQ
BVXVI
BWKFM
CCPQU
CITATION
CS3
D1I
D1J
D1K
DIK
DU5
E3Z
EAP
EAS
EBD
EMOBN
ESX
EX3
F5P
FPL
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HH5
HMCUK
HYE
IAO
IEA
IGS
IHR
IHW
INH
INR
IOV
IPY
ISE
ISR
ITC
K6-
KB.
KQ8
L6V
LK5
LK8
M0K
M1P
M48
M7P
M7R
M7S
M~E
NAPCQ
O5R
O5S
OK1
OVT
P2P
P62
PATMY
PDBOC
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
PTHSS
PYCSY
RNS
RPM
SV3
TR2
UKHRP
WOQ
WOW
~02
~KM
BBORY
CGR
CUY
CVF
ECM
EIF
IPNFZ
NPM
PV9
RIG
RZL
PMFND
3V.
7QG
7QL
7QO
7SN
7SS
7T5
7TG
7TM
7U9
7XB
8FD
8FK
AZQEC
C1K
DWQXO
FR3
GNUQQ
H94
K9.
KL.
M7N
P64
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
PRINS
RC3
7X8
5PM
ADTPV
AGCHP
AOWAS
D8T
D95
ZZAVC
PUEGO
-
02
AAPBV
ABPTK
ADACO
BBAFP
KM
ID FETCH-LOGICAL-c917t-f15a878b8c8fbc2ab1e67d301922c55bb75f113a6e835db98c2971849ea062553
IEDL.DBID M48
ISSN 1932-6203
IngestDate Fri Nov 26 17:14:20 EST 2021
Wed Aug 27 00:49:56 EDT 2025
Thu Aug 21 06:55:11 EDT 2025
Thu Jul 03 05:23:16 EDT 2025
Thu Aug 21 18:33:20 EDT 2025
Fri Jul 11 09:27:59 EDT 2025
Fri Jul 25 10:34:59 EDT 2025
Tue Jun 17 21:25:21 EDT 2025
Tue Jun 10 20:42:03 EDT 2025
Fri Jun 27 04:18:21 EDT 2025
Fri Jun 27 04:10:22 EDT 2025
Thu May 22 21:16:25 EDT 2025
Thu Apr 03 07:06:14 EDT 2025
Tue Jul 01 01:23:02 EDT 2025
Thu Apr 24 22:59:42 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Language English
License This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
Creative Commons Attribution License
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c917t-f15a878b8c8fbc2ab1e67d301922c55bb75f113a6e835db98c2971849ea062553
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Conceived and designed the experiments: MM OM AJ. Performed the experiments: MM OM AJ BH GE PMN. Analyzed the data: MM OM AJ BH GE PMN. Contributed reagents/materials/analysis tools: MM OM AJ BH GE PMN. Wrote the paper: MM OM AJ BH GE PMN.
Competing Interests: The authors have declared that no competing interests exist.
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1371/journal.pone.0089201
PMID 24586593
PQID 1500410997
PQPubID 1436336
PageCount e89201
ParticipantIDs plos_journals_1500410997
doaj_primary_oai_doaj_org_article_6b13e90b265a4c0da0d996a5b63a3517
swepub_primary_oai_portal_research_lu_se_publications_f85f6525_b864_48e1_acc2_d13083e4cebc
swepub_primary_oai_lup_lub_lu_se_f85f6525_b864_48e1_acc2_d13083e4cebc
pubmedcentral_primary_oai_pubmedcentral_nih_gov_3929630
proquest_miscellaneous_1504154267
proquest_journals_1500410997
gale_infotracmisc_A478799044
gale_infotracacademiconefile_A478799044
gale_incontextgauss_ISR_A478799044
gale_incontextgauss_IOV_A478799044
gale_healthsolutions_A478799044
pubmed_primary_24586593
crossref_citationtrail_10_1371_journal_pone_0089201
crossref_primary_10_1371_journal_pone_0089201
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2014-02-19
PublicationDateYYYYMMDD 2014-02-19
PublicationDate_xml – month: 02
  year: 2014
  text: 2014-02-19
  day: 19
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: San Francisco
– name: San Francisco, USA
PublicationTitle PloS one
PublicationTitleAlternate PLoS One
PublicationYear 2014
Publisher Public Library of Science
Public Library of Science (PLoS)
Publisher_xml – name: Public Library of Science
– name: Public Library of Science (PLoS)
References TG Yandle (ref36) 1994; 235
EJ Henriksen (ref8) 2003; 5
ER Levin (ref1) 1998; 339
KL Ellis (ref33) 2011; 50
A Prasad (ref10) 2004; 110
M Magnusson (ref5) 2012; 97
MJ Lopez (ref3) 1995; 378
R Pfister (ref19) 2011; 8
C Li (ref22) 2005; 36
EJ Verspohl (ref15) 1996; 17
S Rubattu (ref17) 2007; 25
G Berglund (ref21) 1993; 233
M Magnusson (ref35) 2004; 27
B Wettermark (ref30) 2007; 16
J Cederholm (ref26) 2008; 31
V Salomaa (ref32) 2010; 5
L Yvan-Charvet (ref13) 2005; 54
C Newton-Cheh (ref4) 2009; 41
S Enhörning (ref25) 2013; 37
DE Uehlinger (ref14) 1986; 8
V Cannone (ref34) 2011; 58
LA Velloso (ref12) 2006; 22
C Newton-Cheh (ref20) 2009; 41
JF Ludvigsson (ref28) 2011; 11
P Arora (ref40) 2013; 123
SW John (ref2) 1995; 267
(ref29) 2003
EA Gale (ref41) 2001; 44
V Cannone (ref39) 2013; 36
MH Olsen (ref16) 2005; 46
J Janke (ref9) 2002; 51
V Lyssenko (ref31) 2008; 359
A Hammerer-Lercher (ref37) 2004; 50
A Jujic (ref38) 2013; 24;14
S Rajagopalan (ref11) 1996; 97
PO Carlsson (ref6) 1998; 41
E Lindholm (ref27) 2001; 17
J Manjer (ref23) 2001; 10
D Fliser (ref7) 2004; 110
TJ Wang (ref18) 2007; 115
M Persson (ref24) 2007; 27
23799939 - BMC Med Genet. 2013;14:64
11206408 - Diabetologia. 2001 Jan;44(1):3-15
19430483 - Nat Genet. 2009 Jun;41(6):666-76
9682046 - N Engl J Med. 1998 Jul 30;339(5):321-8
15313950 - Circulation. 2004 Aug 31;110(9):1103-7
21798427 - J Am Coll Cardiol. 2011 Aug 2;58(6):629-36
23867623 - J Clin Invest. 2013 Aug;123(8):3378-82
12795654 - Diabetes Obes Metab. 2003 Jul;5(4):214-22
7477288 - Nature. 1995 Nov 2;378(6552):65-8
18591403 - Diabetes Care. 2008 Oct;31(10):2038-43
19219041 - Nat Genet. 2009 Mar;41(3):348-53
9498644 - Diabetologia. 1998 Feb;41(2):127-33
21658213 - BMC Public Health. 2011;11:450
8899823 - Peptides. 1996;17(6):1023-9
17431184 - Arterioscler Thromb Vasc Biol. 2007 Jun;27(6):1411-6
12031955 - Diabetes. 2002 Jun;51(6):1699-707
8429286 - J Intern Med. 1993 Jan;233(1):45-51
21276798 - J Mol Cell Cardiol. 2011 Apr;50(4):695-701
22039354 - PLoS Med. 2011 Oct;8(10):e1001112
15142976 - Clin Chem. 2004 Jul;50(7):1174-83
15746450 - Stroke. 2005 Apr;36(4):725-30
16389635 - Diabetes Metab Res Rev. 2006 Mar-Apr;22(2):98-107
12380709 - Eur J Epidemiol. 2001;17(11):983-9
16129819 - Hypertension. 2005 Oct;46(4):660-6
19020324 - N Engl J Med. 2008 Nov 20;359(21):2220-32
2434736 - J Cardiovasc Pharmacol. 1986 Nov-Dec;8(6):1122-9
17339551 - Circulation. 2007 Mar 20;115(11):1345-53
15364819 - Circulation. 2004 Sep 14;110(11):1507-12
17351376 - J Hypertens. 2007 Apr;25(4):833-9
8207362 - J Intern Med. 1994 Jun;235(6):561-76
7839143 - Science. 1995 Feb 3;267(5198):679-81
15277419 - Diabetes Care. 2004 Aug;27(8):1929-35
8621776 - J Clin Invest. 1996 Apr 15;97(8):1916-23
23637347 - Diabetes Care. 2013 Sep;36(9):2850-6
16897791 - Pharmacoepidemiol Drug Saf. 2007 Jul;16(7):726-35
22112816 - J Clin Endocrinol Metab. 2012 Feb;97(2):638-45
22614056 - Int J Obes (Lond). 2013 Apr;37(4):598-603
20396381 - PLoS One. 2010;5(4):e10100
11916347 - Eur J Cancer Prev. 2001 Dec;10(6):489-99
15793237 - Diabetes. 2005 Apr;54(4):991-9
References_xml – volume: 8
  start-page: e1001112
  year: 2011
  ident: ref19
  article-title: Mendelian randomization study of b-type natriuretic peptide and type 2 diabetes: Evidence of causal association from population studies
  publication-title: PLoS Med
  doi: 10.1371/journal.pmed.1001112
– volume: 17
  start-page: 983
  year: 2001
  ident: ref27
  article-title: Classifying diabetes according to the new who clinical stages
  publication-title: Eur J Epidemiol
  doi: 10.1023/A:1020036805655
– volume: 58
  start-page: 629
  year: 2011
  ident: ref34
  article-title: A genetic variant of the atrial natriuretic peptide gene is associated with cardiometabolic protection in the general community
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2011.05.011
– volume: 22
  start-page: 98
  year: 2006
  ident: ref12
  article-title: The multi-faceted cross-talk between the insulin and angiotensin ii signaling systems
  publication-title: Diabetes Metab Res Rev
  doi: 10.1002/dmrr.611
– volume: 50
  start-page: 695
  year: 2011
  ident: ref33
  article-title: Association of genetic variation in the natriuretic peptide system with cardiovascular outcomes
  publication-title: J Mol Cell Cardiol
  doi: 10.1016/j.yjmcc.2011.01.010
– volume: 41
  start-page: 348
  year: 2009
  ident: ref4
  article-title: Association of common variants in nppa and nppb with circulating natriuretic peptides and blood pressure
  publication-title: Nat Genet
  doi: 10.1038/ng.328
– volume: 41
  start-page: 666
  year: 2009
  ident: ref20
  article-title: Genome-wide association study identifies eight loci associated with blood pressure
  publication-title: Nat Genet
  doi: 10.1038/ng.361
– volume: 54
  start-page: 991
  year: 2005
  ident: ref13
  article-title: Deletion of the angiotensin type 2 receptor (at2r) reduces adipose cell size and protects from diet-induced obesity and insulin resistance
  publication-title: Diabetes
  doi: 10.2337/diabetes.54.4.991
– volume: 37
  start-page: 598
  year: 2013
  ident: ref25
  article-title: Copeptin, a marker of vasopressin, in abdominal obesity, diabetes and microalbuminuria: The prospective malmo diet and cancer study cardiovascular cohort
  publication-title: Int J Obes (Lond)
  doi: 10.1038/ijo.2012.88
– volume: 41
  start-page: 127
  year: 1998
  ident: ref6
  article-title: Angiotensin ii and the endocrine pancreas: Effects on islet blood flow and insulin secretion in rats
  publication-title: Diabetologia
  doi: 10.1007/s001250050880
– volume: 123
  start-page: 3378
  issue: 8
  year: 2013
  ident: ref40
  article-title: Atrial natriuretic peptide is negatively regulated by microRNA-425
  publication-title: J Clin Invest
  doi: 10.1172/JCI67383
– volume: 5
  start-page: 214
  year: 2003
  ident: ref8
  article-title: Angiotensin converting enzyme inhibitors and modulation of skeletal muscle insulin resistance
  publication-title: Diabetes Obes Metab
  doi: 10.1046/j.1463-1326.2003.00265.x
– volume: 16
  start-page: 726
  year: 2007
  ident: ref30
  article-title: The new swedish prescribed drug register–opportunities for pharmacoepidemiological research and experience from the first six months
  publication-title: Pharmacoepidemiol Drug Saf
  doi: 10.1002/pds.1294
– volume: 267
  start-page: 679
  year: 1995
  ident: ref2
  article-title: Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension
  publication-title: Science
  doi: 10.1126/science.7839143
– volume: 233
  start-page: 45
  year: 1993
  ident: ref21
  article-title: The malmo diet and cancer study. Design and feasibility
  publication-title: J Intern Med
  doi: 10.1111/j.1365-2796.1993.tb00645.x
– volume: 31
  start-page: 2038
  year: 2008
  ident: ref26
  article-title: Risk prediction of cardiovascular disease in type 2 diabetes: A risk equation from the swedish national diabetes register
  publication-title: Diabetes Care
  doi: 10.2337/dc08-0662
– volume: 44
  start-page: 3
  issue: 1
  year: 2001
  ident: ref41
  article-title: Diabetes and gender
  publication-title: Diabetologia
  doi: 10.1007/s001250051573
– volume: 46
  start-page: 660
  year: 2005
  ident: ref16
  article-title: N-terminal pro brain natriuretic peptide is inversely related to metabolic cardiovascular risk factors and the metabolic syndrome
  publication-title: Hypertension
  doi: 10.1161/01.HYP.0000179575.13739.72
– volume: 115
  start-page: 1345
  year: 2007
  ident: ref18
  article-title: Association of plasma natriuretic peptide levels with metabolic risk factors in ambulatory individuals
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.106.655142
– volume: 378
  start-page: 65
  year: 1995
  ident: ref3
  article-title: Salt-resistant hypertension in mice lacking the guanylyl cyclase-a receptor for atrial natriuretic peptide
  publication-title: Nature
  doi: 10.1038/378065a0
– volume: 110
  start-page: 1507
  year: 2004
  ident: ref10
  article-title: Renin-angiotensin system and angiotensin receptor blockers in the metabolic syndrome
  publication-title: Circulation
  doi: 10.1161/01.CIR.0000141736.76561.78
– volume: 11
  start-page: 450
  year: 2011
  ident: ref28
  article-title: External review and validation of the swedish national inpatient register
  publication-title: BMC Public Health
  doi: 10.1186/1471-2458-11-450
– volume: 36
  start-page: 725
  year: 2005
  ident: ref22
  article-title: Blood pressure control and risk of stroke: A population-based prospective cohort study
  publication-title: Stroke
  doi: 10.1161/01.STR.0000158925.12740.87
– volume: 36
  start-page: 2850
  issue: 9
  year: 2013
  ident: ref39
  article-title: The atrial natriuretic peptide genetic variant rs5068 is associated with a favorable cardiometabolic phenotype in a Mediterranean population
  publication-title: Diabetes Care
  doi: 10.2337/dc12-2337
– volume: 97
  start-page: 1916
  year: 1996
  ident: ref11
  article-title: Angiotensin ii-mediated hypertension in the rat increases vascular superoxide production via membrane nadh/nadph oxidase activation. Contribution to alterations of vasomotor tone
  publication-title: J Clin Invest
  doi: 10.1172/JCI118623
– volume: 8
  start-page: 1122
  year: 1986
  ident: ref14
  article-title: Increase in circulating insulin induced by atrial natriuretic peptide in normal humans
  publication-title: J Cardiovasc Pharmacol
  doi: 10.1097/00005344-198611000-00005
– volume: 17
  start-page: 1023
  year: 1996
  ident: ref15
  article-title: Atrial natriuretic peptide (anp)-induced inhibition of glucagon secretion: Mechanism of action in isolated rat pancreatic islets
  publication-title: Peptides
  doi: 10.1016/0196-9781(96)00152-0
– volume: 27
  start-page: 1929
  year: 2004
  ident: ref35
  article-title: Elevated plasma levels of nt-probnp in patients with type 2 diabetes without overt cardiovascular disease
  publication-title: Diabetes Care
  doi: 10.2337/diacare.27.8.1929
– volume: 50
  start-page: 1174
  year: 2004
  ident: ref37
  article-title: Natriuretic peptides as markers of mild forms of left ventricular dysfunction: Effects of assays on diagnostic performance of markers
  publication-title: Clin Chem
  doi: 10.1373/clinchem.2003.028316
– volume: 51
  start-page: 1699
  year: 2002
  ident: ref9
  article-title: Mature adipocytes inhibit in vitro differentiation of human preadipocytes via angiotensin type 1 receptors
  publication-title: Diabetes
  doi: 10.2337/diabetes.51.6.1699
– volume: 235
  start-page: 561
  year: 1994
  ident: ref36
  article-title: Biochemistry of natriuretic peptides
  publication-title: J Intern Med
  doi: 10.1111/j.1365-2796.1994.tb01263.x
– volume: 339
  start-page: 321
  year: 1998
  ident: ref1
  article-title: Natriuretic peptides
  publication-title: N Engl J Med
  doi: 10.1056/NEJM199807303390507
– volume: 10
  start-page: 489
  year: 2001
  ident: ref23
  article-title: The Malmo diet and cancer study: Representativity, cancer incidence and mortality in participants and non-participants
  publication-title: Eur J Cancer Prev
  doi: 10.1097/00008469-200112000-00003
– year: 2003
  ident: ref29
  article-title: A finger on the pulse. Monitoring public health and social conditions in sweden 1992–2002
  publication-title: Stockholm
– volume: 24;14
  start-page: 64
  issue: 1
  year: 2013
  ident: ref38
  article-title: A genetic variant of the atrial natriuretic peptide gene is associated with left ventricular hypertrophy in a non-diabetic population - the Malmo preventive project study
  publication-title: BMC Med Genet
  doi: 10.1186/1471-2350-14-64
– volume: 359
  start-page: 2220
  year: 2008
  ident: ref31
  article-title: Clinical risk factors, DNA variants, and the development of type 2 diabetes
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa0801869
– volume: 27
  start-page: 1411
  year: 2007
  ident: ref24
  article-title: Elevated lp-pla2 levels add prognostic information to the metabolic syndrome on incidence of cardiovascular events among middle-aged nondiabetic subjects
  publication-title: Arterioscler Thromb Vasc Biol
  doi: 10.1161/ATVBAHA.107.142679
– volume: 110
  start-page: 1103
  year: 2004
  ident: ref7
  article-title: Antiinflammatory effects of angiotensin ii subtype 1 receptor blockade in hypertensive patients with microinflammation
  publication-title: Circulation
  doi: 10.1161/01.CIR.0000140265.21608.8E
– volume: 5
  start-page: e10100
  year: 2010
  ident: ref32
  article-title: Thirty-one novel biomarkers as predictors for clinically incident diabetes
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0010100
– volume: 25
  start-page: 833
  year: 2007
  ident: ref17
  article-title: Reduced levels of n-terminal-proatrial natriuretic peptide in hypertensive patients with metabolic syndrome and their relationship with left ventricular mass
  publication-title: J Hypertens
  doi: 10.1097/HJH.0b013e32803cae3c
– volume: 97
  start-page: 638
  year: 2012
  ident: ref5
  article-title: Low plasma level of atrial natriuretic peptide predicts development of diabetes: The prospective Malmo diet and cancer study
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2011-2425
– reference: 16897791 - Pharmacoepidemiol Drug Saf. 2007 Jul;16(7):726-35
– reference: 15746450 - Stroke. 2005 Apr;36(4):725-30
– reference: 15277419 - Diabetes Care. 2004 Aug;27(8):1929-35
– reference: 8621776 - J Clin Invest. 1996 Apr 15;97(8):1916-23
– reference: 15793237 - Diabetes. 2005 Apr;54(4):991-9
– reference: 22112816 - J Clin Endocrinol Metab. 2012 Feb;97(2):638-45
– reference: 23799939 - BMC Med Genet. 2013;14:64
– reference: 21658213 - BMC Public Health. 2011;11:450
– reference: 12795654 - Diabetes Obes Metab. 2003 Jul;5(4):214-22
– reference: 15142976 - Clin Chem. 2004 Jul;50(7):1174-83
– reference: 9498644 - Diabetologia. 1998 Feb;41(2):127-33
– reference: 17351376 - J Hypertens. 2007 Apr;25(4):833-9
– reference: 16389635 - Diabetes Metab Res Rev. 2006 Mar-Apr;22(2):98-107
– reference: 12380709 - Eur J Epidemiol. 2001;17(11):983-9
– reference: 2434736 - J Cardiovasc Pharmacol. 1986 Nov-Dec;8(6):1122-9
– reference: 17339551 - Circulation. 2007 Mar 20;115(11):1345-53
– reference: 19020324 - N Engl J Med. 2008 Nov 20;359(21):2220-32
– reference: 8899823 - Peptides. 1996;17(6):1023-9
– reference: 21276798 - J Mol Cell Cardiol. 2011 Apr;50(4):695-701
– reference: 23637347 - Diabetes Care. 2013 Sep;36(9):2850-6
– reference: 7839143 - Science. 1995 Feb 3;267(5198):679-81
– reference: 11206408 - Diabetologia. 2001 Jan;44(1):3-15
– reference: 22039354 - PLoS Med. 2011 Oct;8(10):e1001112
– reference: 22614056 - Int J Obes (Lond). 2013 Apr;37(4):598-603
– reference: 23867623 - J Clin Invest. 2013 Aug;123(8):3378-82
– reference: 19219041 - Nat Genet. 2009 Mar;41(3):348-53
– reference: 11916347 - Eur J Cancer Prev. 2001 Dec;10(6):489-99
– reference: 17431184 - Arterioscler Thromb Vasc Biol. 2007 Jun;27(6):1411-6
– reference: 12031955 - Diabetes. 2002 Jun;51(6):1699-707
– reference: 18591403 - Diabetes Care. 2008 Oct;31(10):2038-43
– reference: 8429286 - J Intern Med. 1993 Jan;233(1):45-51
– reference: 8207362 - J Intern Med. 1994 Jun;235(6):561-76
– reference: 19430483 - Nat Genet. 2009 Jun;41(6):666-76
– reference: 15364819 - Circulation. 2004 Sep 14;110(11):1507-12
– reference: 16129819 - Hypertension. 2005 Oct;46(4):660-6
– reference: 21798427 - J Am Coll Cardiol. 2011 Aug 2;58(6):629-36
– reference: 7477288 - Nature. 1995 Nov 2;378(6552):65-8
– reference: 15313950 - Circulation. 2004 Aug 31;110(9):1103-7
– reference: 20396381 - PLoS One. 2010;5(4):e10100
– reference: 9682046 - N Engl J Med. 1998 Jul 30;339(5):321-8
SSID ssj0053866
Score 2.3196573
Snippet We have recently shown that low plasma levels of mid-regional atrial natriuretic peptide (MR-ANP) predict development of diabetes and glucose progression over...
Background We have recently shown that low plasma levels of mid-regional atrial natriuretic peptide (MR-ANP) predict development of diabetes and glucose...
BackgroundWe have recently shown that low plasma levels of mid-regional atrial natriuretic peptide (MR-ANP) predict development of diabetes and glucose...
Background We have recently shown that low plasma levels of mid-regional atrial natriuretic peptide (MR-ANP) predict development of diabetes and glucose...
SourceID plos
doaj
swepub
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage e89201
SubjectTerms Age Factors
Analysis
Atrial Natriuretic Factor - blood
Atrial Natriuretic Factor - genetics
Atrial natriuretic peptide
Biology
Biomarkers
Body mass
Body Mass Index
Cancer
Cancer research
Cardiac and Cardiovascular Systems
Cardiology and Cardiovascular Disease
Cardiovascular disease
Clinical Medicine
Development and progression
Diabetes
Diabetes mellitus
Diabetes Mellitus, Type 2 - epidemiology
Diabetes Mellitus, Type 2 - genetics
Diabetes Mellitus, Type 2 - metabolism
Emergency medical care
Etiology
Fasting
Female
Gene polymorphism
Genetic aspects
Genotype
Glucose
Health risks
Heart failure
Hospitals
Humans
Hypertension
Insulin resistance
Kardiologi
Kardiologi och kardiovaskulära sjukdomar
Klinisk medicin
Loci
Male
Medical and Health Sciences
Medicin och hälsovetenskap
Medicine
Natriuretic peptides
Peptides
Physiology
Plasma
Plasma levels
Polymorphism
Polymorphism, Single Nucleotide - genetics
Population
Proportional Hazards Models
Public health
Regional development
Regression Analysis
Risk analysis
Risk factors
Rodents
Sex Factors
Single nucleotide polymorphisms
Single-nucleotide polymorphism
Studies
Sweden - epidemiology
Type 2 diabetes
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELbQnrggyquBBQJCAg6hSfxIclxQq4IESEBRxcXykyJV2ajZ_f_MOE7aiJXaA4dc4i-WPDO2x87MN4S8apTNrRMm0x5LmDknMuVzn1UejFl7YVVIj_78RRyfsE-n_PRKqS-MCRvogQfBHQhdUNfkuhRcMZNblVtw0RXXgirKi5BHDnveeJga1mCYxULERDlaFQdRL--6deuQ0LQpYxGYcSMKfP3Tqrzoztf9Lpfz38jJGb9o2JOO7pI70ZlMV8Mg9sgt194je3G69umbyCn99j6xq1CeI22RkX8bMhfTDgNarEtVa1O8iU3LdLyJTe1lLFGWYYo-RvFcBCiyuga4utRsGlhqH5CTo8MfH46zWGAhM3BK22S-4Kqual2b2mtTKl04UVmKXl9pONe64r4oqBIO_DSrm9qUDexlrHEqh3MTpw_JogWR7pMUVK1rZinLjWXMgRfkhfC-amztK61cQugobWki-zgWwTiX4ZdaBaeQQWYSdSSjjhKSTV91A_vGNfj3qMgJi9zZ4QVYlIwWJa-zqIQ8RzOQQyLqtALIFfIYwebNWEJeBgTyZ7QYoPNbbftefvz68wag799moNcR5NcgDqNiUgSMCXm5ZsjlDAmrgJk176PRjlLpJTj6OcPfnjCe5WjIu5tfTM3YKQbdtW69DRhw78CFA8yjwe4nyZaM14I3NCHVbEbMRD9vaf-cBfpy9MgFzRNyOMyd2Sfn2w4eDY_snfQ194KXXOpaMMlqV0hlTCkteF41dcw4bRLya0c_w-FVRsass9hfd-Uq_EadP_4fBvWE3AbbZBjrXzRLsthcbN1TcGU3-llYtf4CwIag8A
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwELagXJAQouXRQAGDkIBDaB62k5xQi1oVJAoCiioulp9tpZIsTffAjf_AP-SXMON4QyMq6CGX9djSzsOesWe-IeRJo2xmnTCp9tjCzDmRKp_5tPKgzNoLq0J59NtdsbPH3uzz_Xjh1se0ysWeGDZq2xm8I18HxyVj-IxTvZx9S7FrFL6uxhYal8kVhC7DlK5qfwy4wJaFiOVyZZWvR-m8mHWtQ1jTpoitYBbHUUDtH_fmpdlx15_neP6dPzlBGQ0n0_YNcj26lHRj0IFlcsm1K-TacB9HhzKjFbIcjbinzyLS9POb5GAjNO2gu4jTPw_1jPQ9prlYR1VrKQaptKAxa6anZzKM6K8fP-nmUfcV03tOAjWs2-GNLj0jcop5it9vkb3trU-vdtLYeSE1EL6dpj7nqq5qXZvaa1MonTtR2RLdwcJwrnXFfZ6XSjhw4KxualM0cMixxqkMAipe3iZLLXB5lVDQAV0zW7LMWMYcuEdeCO-rxta-0solpFwIQJoIS47dMY5leGurIDwZ2ChRbDKKLSHpOGs2wHL8h34TZTvSIqh2-KE7OZDRRqXQeemaTBeCK2YyqzIL0aDiWpSq5HmVkIeoGXKoUB23BrmBAEdwqjOWkMeBAoE1WszcOVDzvpev332-ANHHDxOip5HId8AOo2K1BPwnBOyaUK5NKGF7MJPhVdTjBVd6-ceQYOZCt88ffjQO46KYjde6bh5owO8D3w5o7gymMHK2YLwWvCkTUk2MZML66Uh7dBhwzdFVF2WWkK3BnCZTjucz-DR8snfS19wLXnCpa8Ekq10ulTGFtOCS1aVjxmmTkC_nrDNEtTJCaR3G9WZn7sgvtPjdf_PuHrkKWscwvT9v1sjS6cnc3Qfv9VQ_CFvUb3WInn4
  priority: 102
  providerName: ProQuest
Title Atrial Natriuretic Peptide and Type 2 Diabetes Development – Biomarker and Genotype Association Study
URI https://www.ncbi.nlm.nih.gov/pubmed/24586593
https://www.proquest.com/docview/1500410997
https://www.proquest.com/docview/1504154267
https://pubmed.ncbi.nlm.nih.gov/PMC3929630
https://lup.lub.lu.se/record/4384156
oai:portal.research.lu.se:publications/f85f6525-b864-48e1-acc2-d13083e4cebc
https://doaj.org/article/6b13e90b265a4c0da0d996a5b63a3517
http://dx.doi.org/10.1371/journal.pone.0089201
Volume 9
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3NbtQwELZKe0FCiJafBspiEBJw2Co_tpMcEGqrLQWppSoUVVws27HbSkuybLoSvSDegTfkSZhxslEjtoJDcojHljKesWfsmW8IeZ6rIiysMEPtsISZtWKoXOiGqQNh1k4UyqdH7x-IvWP2_oSfLJF5zdaWgfVC1w7rSR1Px5vfv12-AYV_7as2pNG80-akKi3CleYxJnStwN6Uoqrus-5eAbRbiDaB7rqevQ3K4_h3q_XyZFzVi0zRvyMqe7ijfq_avUNut0Ym3WqkYpUs2XKN3GpO6GiTeLRGVlu1runLFnv61V1yuuXLeNADRO6f-QxHeoiBL4Wlqiwouq00pm0cTU2vxBzR3z9_0e3z6isG_Ew9NYxb4RkvvSIEFCMXL--R493Rp529YVuLYWjAobsYuoirLM10ZjKnTax0ZEVaJGggxoZzrVPuoihRwoJJV-g8M3EO2x7LrQrBxeLJfbJcApfXCQWp0BkrEhaagjELBpMTwrk0LzKXamUDkswnQJoWqBzrZYylv31LwWFp2Chx2mQ7bQEZdr0mDVDHP-i3cW47WoTZ9h-q6alstVYKHSU2D3UsuGImLFRYgH-ouBaJSniUBuQJSoZscla7xUJuIeQR7POMBeSZp0CojRJjeU7VrK7luw-f_4Po41GP6EVL5Cpgh1Ft_gT8E0J49Sg3epSwYJhe8zrK8ZwrtQSfIGR4Qwr_szGX7cXNT7tmHBTj80pbzTwNWIJg7QHNg0YVOs7GjGeC50lA0p6S9FjfbynPzzzSORrvIgkDMmrUqddlPJvAo-GRtZUu407wmEudCSZZZiOpjIllAUZallhmrDYB-bJgnGaJkS241lk73uTKqfl_Df7werY-IjdB4hgG-0f5Blm-mM7sY7BlL_SA3EhPUnhnOxG-d98OyMr26ODwaOBPhwZ--cL3j9Ef0Xio4A
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3LbtUwELWqsgAJIVoeDRRqEAhYhObhOMkCoRZatfQBghZdsTG2Y7eVSnJpeoW64x_4Dz6KL2EmcUIjKuimi2yujy3dmfF4xp4HIY9yWQSF4dpXFluYGcN9aQPrpxaEWVleyCY9emubr-2yN6NkNEV-drkwGFbZ6cRGUReVxjvyRTBcAobPOOnL8Vcfu0bh62rXQqMViw1z8g1ctvrF-mvg7-MoWl3ZebXmu64CvgbX5Ni3YSKzNFOZzqzSkVSh4WkRo6kT6SRRKk1sGMaSGzBOCpVnOspBgbPcyACcBewSASr_Ehy8Ae6odNQ7eKA7OHfpeXEaLjppeD6uSoNlVPPItZ7pjr-mS0B_FkyPD6v6LEP373jNQVXT5iRcvU6uOROWLrUyN0OmTDlLrrb3f7RNa5olM05p1PSpq2z97AbZW2qahNBt7AswafIn6TsMqykMlWVB0SmmEXVROjU9FdFEf33_QZcPqi8YTnTUoGHdCm-Q6SkRoxgXeXKT7F4IT26R6RKoPEcoyJzKWBGzQBeMGTDHLOfWpnmR2VRJ45G4Y4DQrgw6duM4FM3bXgruUEtGgWwTjm0e8ftZ47YMyH_wy8jbHotFvJsfqqM94XSC4CqMTR6oiCeS6aCQQQHep0wUj2WchKlHFlAyRJsR26sisYQFlcCKYMwjDxsEFvIoMVJoT07qWqy__XgO0If3A9ATB7IVkENLl50B_wkLhA2Q8wMkqCM9GJ5DOe6oUos_GxdmdrJ99vCDfhgXxei_0lSTBgN2JtiSgLndboWeshFLMp7ksUfSwSYZkH44Uh7sN3XU0TXgceCRlXY7DaYcTsbwKfhEbYTNEsuTKBEq40ywzIRCah2JAkzALDZMG6U98umMdVovWrjSXftuvfGpO_lzLX7n37RbIJfXdrY2xeb69sZdcgUkkGFqQZjPk-njo4m5B5bzsbrfqCtKPl-0fvwNq7baew
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bT9VAEN4QTIyJMYIXqiir0agPlV622_bBGBCIiCJRMcSXda9Agu2RcmJ48z_4b_w5_hJn2j2VRqK88NCXs7ObnJnZb2d250LIg1KayFiuQ-WwhZm1PJQucmHuQJmV40a26dFvNvnLbfZqJ9uZIj8nuTAYVjnBxBaoTa3xjnwRDJeI4TNOvuh8WMTWytrz0dcQO0jhS-uknUanIhv2-Bu4b82z9RWQ9cMkWVv98OJl6DsMhBrclKPQxZks8kIVunBKJ1LFlucmRbMn0VmmVJ65OE4lt2CoGFUWOikBzFlpZQSOA3aMAPi_kKdZjHss3-mdPcARzn2qXprHi14zno7qymJJ1TLxbWgmR2HbMaA_F6ZHB3VzmtH7d-zmoMJpeyquXSVXvDlLlzr9myFTtpoll7u7QNqlOM2SGQ8gDX3sq1w_uUZ2l9qGIXQTewSM21xKuoUhNsZSWRmKDjJNqI_YaeiJ6Cb66_sPurxff8HQosOWGtat8TaZnlA3ijGSx9fJ9rnI5AaZroDLc4SC_qmCmZRF2jBmwTRznDuXl6ZwuZI2IOlEAEL7kujYmeNAtO98ObhGHRsFik14sQUk7GeNupIg_6FfRtn2tFjQu_2hPtwVHh8EV3Fqy0glPJNMR0ZGBjxRmSmeStCuPCALqBmiy47tYUksYXElsCgYC8j9lgKLelS4PXbluGnE-tuPZyB6_25A9MgTuRrYoaXP1ID_hMXCBpTzA0qAJj0YnkM9nnClEX82Mcyc6Pbpw_f6YVwUIwErW49bGrA5wa4EmpvdVug5m7Cs4FmZBiQfbJIB64cj1f5eW1Md3QSeRgFZ7bbTYMrBeASfgk80VrgiczxLMqEKzgQrbCyk1okwYA4WqWXaKh2QT6es03nUwpfx2vPrjU7cz59p8Vv_5t0CuQjIKF6vb27cJpdAARlmGcTlPJk-OhzbO2BEH6m7LVpR8vm84fE3-JDesQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Atrial+Natriuretic+Peptide+and+Type+2+Diabetes+Development+%E2%80%93+Biomarker+and+Genotype+Association+Study&rft.jtitle=PloS+one&rft.au=Juji%C4%87%2C+Amra&rft.au=Nilsson%2C+Peter&rft.au=Engstr%C3%B6m%2C+Gunnar&rft.au=Hedblad%2C+Bo&rft.date=2014-02-19&rft.pub=Public+Library+of+Science&rft.eissn=1932-6203&rft.volume=9&rft.issue=2&rft_id=info:doi/10.1371%2Fjournal.pone.0089201&rft.externalDocID=1500410997
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1932-6203&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1932-6203&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1932-6203&client=summon